# Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

Study · id `cardio:ct-nct06095765` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06095765](<https://clinicaltrials.gov/study/NCT06095765>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06095765

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2770 participants.

## Technical summary

Registry record NCT06095765. Randomized; single masking; primary purpose prevention. Start 2024-01-29 (actual); primary completion 2027-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 2770 participants (planned count; ClinicalTrials.gov record NCT06095765, source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)
- Started: 2024-01-29 (actual) (ClinicalTrials.gov record NCT06095765, source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)
- Primary completion: 2027-11-01 (anticipated) (ClinicalTrials.gov record NCT06095765, source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)
- Completion: 2028-03-01 (anticipated) (ClinicalTrials.gov record NCT06095765, source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT06095765, source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06095765-2024-03-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
- Acronym: COL BE PCI
- Condition: Coronary Artery Disease
- Intervention (Drug): Colchicine 0.5 MG Oral Tablet
- Intervention (Drug): Placebo
- Lead sponsor: AZ Sint-Jan AV
- Lead sponsor class: OTHER
- Collaborator: University Hospital, Ghent
- Collaborator class: OTHER
- Collaborator: Belgium Health Care Knowledge Centre
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: AZ Sint-Jan AV (`cardio:org-az-sint-jan-av`)
- Registry lists this organization as a collaborator: University Hospital, Ghent (`cardio:org-university-hospital-ghent`)

## Provenance

Content hash: a303092228f03c2a53dd5509e1f42b0f1858e8939c07f7fb997bf834bc80213e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
